Профиль компании
- Фондовый код
- 326030
- ISIN-код
- KR7326030004
- Валюта
- Korean Won (KRW)

SK Biopharmaceuticals Co., Ltd., a pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders. The company offers Cenobamate, an anti-seizure medication for the treatment of epilepsy and Solriamfetol medication. It develops Carisbamate that is in Phase 3 trials to treat l...